Mphasis BFL- Several headwinds to EPS growth; SELL.: Kotak Sec

Visit http://indiaer.blogspot.com/ for complete details �� ��


Mphasis BFL (MPHL)
Technology
Several headwinds to EPS growth in FY ending Oct 2011E; SELL. With the postresults
bounce (a reversal of pre-results underperformance driven by Street’s fears of a
poor quarter) behind us, we believe it is prudent to focus on the EPS growth headwinds
facing Mphasis in FY2012E. Margins face pressure from a stronger Re, lower cash flow
hedging gains and tight supply environment in addition to the structural pricing
pressure. Increase in ETR is likely to pressure EPS growth further. Reiterate SELL.

Entertainment Network — Ruling The Airwaves: Ambit

Visit http://indiaer.blogspot.com/ for complete details �� ��

INITIATING COVERAGE
Entertainment Network — Ruling The Airwaves

Initiating coverage with a BUY rating
We initiate coverage on ENIL with a BUY. We value ENIL on a SOTP basis with a TP of Rs275 (Radio Mirchi: DCF valuation Rs260/sh plus Event Management at 1yr fwd1x EV/sales Rs15/sh). This indicates an upside of 25% from current levels. In our view, improving ad spend, changes in the royalty structure and announcement of phase 3 policy will transform business dynamics of the radio industry. ENIL, the leading player, is expected to benefit the most.

MOIL, Claris,Shipping Corp IPO/FPO gray market premium : Nov 24th, 2010

Visit http://indiaer.blogspot.com/ for complete details �� ��

Company Name	Offer Price	Premium
	(Rs.)	(Rs.)
RPP Infra Projects	68 to 75	4 to 6
Manganese Ore (MOIL)	340-375  (+ 5% retail discount)	205 to 215
Claris Life	278-293	44 to 49
Shipping Corp FPO	120- 130(rumor)	12 to 15

CLARIS LIFESCIENCES LIMITED - Almost No subscribers on Day 1 of IPO

Total Issue Size	8848921
Total Bids Received	209902
Total Bids Received at Cut-off Price	158664
No. of times issue is subscribed	0.02

Sr.No.	Category	No.of shares offered/reserved	No. of shares bid for	No. of times of total meant for the category
1	Qualified Institutional Buyers (QIBs)	4572152	0	0.00
1(a)	Foreign Institutional Investors (FIIs)		0
1(b)	Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)		0
1(c)	Mutual Funds		0
1(d)	Others		0
2	Non Institutional Investors	1069192	0	0.00
2(a)	Corporates		0
2(b)	Individuals (Other than RIIs)		0
2(c)	Others		0
3	Retail Individual Investors (RIIs)	3207577	209902	0.07
3(a)	Cut Off		123200
3(b)	Price Bids		86702

Updated as on 24 November 2010 at 1700 hrs

FII DERIVATIVES STATISTICS FOR 24-Nov-2010

Visit http://indiaer.blogspot.com/ for complete details �� ��

FII DERIVATIVES STATISTICS FOR 24-Nov-2010
	BUY		SELL		OPEN INTEREST AT THE END OF THE DAY
	No. of contracts	Amt in Crores	No. of contracts	Amt in Crores	No. of contracts	Amt in Crores
INDEX FUTURES	240433	7160.56	256560	7642.52	692600	20378.83	-481.96
INDEX OPTIONS	443568	13126.17	440523	13080.83	1982753	58151.74	45.33
STOCK FUTURES	347449	9557.37	336323	9299.30	1496705	39986.37	258.08
STOCK OPTIONS	16790	525.41	17252	542.80	31925	866.65	-17.39
						TOTAL	-195.94

FII & DII trading activity on NSE and BSE as on 24-Nov-2010

Visit http://indiaer.blogspot.com/ for complete details �� ��

FII trading activity on NSE and BSE on Capital Market Segment

The following is combined FII trading data across NSE and BSE collated on the basis of trades executed by FIIs on 24-Nov-2010.

FII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores) Category Date Buy Value Sell Value Net Value FII 24-Nov-2010 3173.82 3647.13 -473.31

 

Domestic Institutional Investors trading activity on NSE and BSE on Capital Market Segment

The following is combined Domestic Institutional Investors trading data across NSE and BSE collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System on 24-Nov-2010.

DII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores) Category Date Buy Value Sell Value Net Value DII 24-Nov-2010 1311.23 1406.17 -94.94

Claris Lifesciences IPO - Subscribe : Angel Broking

Visit http://indiaer.blogspot.com/ for complete details �� ��

Claris Lifesciences – IPO Note

Angel Broking recommends a Subscribe on Claris Lifesciences IPO.

Claris is one of the largest sterile injectables pharmaceutical companies in India

with a presence in 76 countries worldwide. With a strong portfolio of 113

products, Claris caters to multiple markets and across therapeutic areas including

the anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral

nutrition, parenteral nutrition and oncology segments.

NSE, Bulk deals, 24-Nov-2010

Visit http://indiaer.blogspot.com/ for complete details �� ��

Symbol	Security Name	Client Name	Buy / Sell	Quantity Traded	Wght. Avg.  Price
DHANUS	Dhanus Technologies Limit	UCO BANK	SELL	1,70,964	15.48
GLORY	Glory Polyfilms Limited	RAJ FINVEST	BUY	339	9.05
GLORY	Glory Polyfilms Limited	RAJ FINVEST	SELL	2,97,931	9.22
GLORY	Glory Polyfilms Limited	TRANS FINANCIAL RESOURCES LTD	BUY	6,60,892	9.23
GLORY	Glory Polyfilms Limited	TRANS FINANCIAL RESOURCES LTD	SELL	7,18,453	9.22
GRAVITA	Gravita India Limited	ADVANCE INDIA SECURITIES ANUJ GARG	SELL	76,000	260.27